Monday, July 30, 2018

Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins


Breast cancer cells cultured in a 3D ECM-based model demonstrated altered sensitivity to doxorubicin, when compared to those grown in corresponding two-dimensional (2D) monolayer culture conditions. Investigations into the factors triggering the observed doxorubicin resistance revealed that cell-to-ECM interactions played a pivotal role. This finding correlated with the up-regulation of pro-survival proteins in 3D ECM-containing cell culture conditions following exposure to doxorubicin. Inhibition of integrin signalling in combination with doxorubicin significantly reduced breast cancer cell viability.

 #Breast_Cancer2018 are delightedly invite all the #Experts to #Explore your #research in #Breast_Cancer 2018 Conference on #October 15-16,2018 @Rome, Italy
be a #Speaker #Share your #Research with our #Grand Event
#Abstract_Submission and #Registration has been Officially opened now..!!

Do visit the Site at-https://breastcancer.pulsusconference.com/
Abstract Submission-https://breastcancer.pulsusconference.com/abstract-submission
Registration url-https://breastcancer.pulsusconference.com/registration

Drop your query at-breastcancer@pulsusevents.org /breastcancer@pulsusmeet.org


No comments:

Post a Comment

Obstetrics and Gynecology | Paris, France

Gynecologic cancers are treated in several ways. It depends on the kind of cancer and how far it has spread. Treatments include surger...